Waters Corporation Reports Strong 2025 Financial Results and Provides 2026 Outlook

Details

The company's total sales for the full year increased by 7% to $3,165 million, and non-GAAP earnings per share (EPS) grew to $13.13. The company also provided guidance for 2026, expecting organic constant currency revenue growth in the range of 5.5% to 7.0%, with full-year non-GAAP EPS projected to be between $14.30 and $14.50. The positive financial performance was driven by growth in all end-markets and across all geographic regions.

Items reported

About Waters Corporation

Waters Corporation is a leading entity in the field of analytical instruments and software. It primarily focuses on providing laboratory solutions for a variety of sectors, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. The company's offerings include high-performance liquid chromatography, mass spectrometry systems, and various supporting technologies used for advanced research in life sciences. Waters Corporation is pivotal in enhancing laboratory productivity, offering cutting-edge research tools that assist in drug development, quality control, and environmental testing. Operating globally, it serves a wide array of clients, including academic institutions, government agencies, and private industry players. With its commitment to innovation and precision, Waters Corporation plays a crucial role in advancing scientific and technological progress in multiple critical industries worldwide.